VEXAS Syndrome: UBA1 Mutations Drive Inflammation and Myeloid Bias
The study investigates how UBA1 mutations in VEXAS syndrome lead to inflammation and myeloid cell bias, revealing mechanisms involving aberrant cell death and ubiquitin pathway defects, and suggesting potential therapeutic targets.